Physician profile
Aaron Alme
NPI 1245359223
$1,031.44
in general payments reported to CMS, 2019-2025
12 companies · $356 in 2025
The $356 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $13.25 · 2022: $76.33 · 2023: $107 · 2024: $356 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $224.59 | 2022-2025 | Vabysmo, Susvimo |
| Rxsight INC | $204.38 | 2024-2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Regeneron Healthcare Solutions, INC. | $204.02 | 2019-2025 | Eylea Hd, Eylea |
| Astellas Pharma US INC | $109.38 | 2023-2025 | Izervay |
| Allergan, INC. | $65.00 | 2019 | |
| Alcon Vision LLC | $58.94 | 2022-2025 | Hydrus Microstent, Constellation |
| Johnson & Johnson Surgical Vision, INC. | $53.67 | 2024 | Healon Duet Pro, Tecnis Simplicity |
| The Cameron-Ehlen Group, INC. | $31.28 | 2019-2022 | |
| Abbvie INC. | $30.82 | 2023-2024 | Alphagan P |
| Harrow Eye, LLC | $18.85 | 2025 | Iheezo |
| Bausch & Lomb Americas INC. | $17.26 | 2024 | Envista Mx60 Iol |
| Sun Pharmaceutical Industries INC. | $13.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Alme listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.